These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 17114664
1. Patient and treatment factors associated with complications after prostate brachytherapy. Chen AB, D'Amico AV, Neville BA, Earle CC. J Clin Oncol; 2006 Nov 20; 24(33):5298-304. PubMed ID: 17114664 [Abstract] [Full Text] [Related]
2. Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy. Kollmeier MA, Stock RG, Cesaretti J, Stone NN. J Urol; 2005 Mar 20; 173(3):808-12. PubMed ID: 15711274 [Abstract] [Full Text] [Related]
3. Provider case volume and outcomes following prostate brachytherapy. Chen AB, D'Amico AV, Neville BA, Steyerberg EW, Earle CC. J Urol; 2009 Jan 20; 181(1):113-8; discussion 118. PubMed ID: 19012905 [Abstract] [Full Text] [Related]
4. Long-term potency preservation following brachytherapy for prostate cancer. Snyder KM, Stock RG, Buckstein M, Stone NN. BJU Int; 2012 Jul 20; 110(2):221-5. PubMed ID: 22734475 [Abstract] [Full Text] [Related]
8. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients. Keyes M, Miller S, Moravan V, Pickles T, McKenzie M, Pai H, Liu M, Kwan W, Agranovich A, Spadinger I, Lapointe V, Halperin R, Morris WJ. Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1023-32. PubMed ID: 19111402 [Abstract] [Full Text] [Related]
9. Long-term treatment related complications of brachytherapy for early prostate cancer: a survey of patients previously treated. Talcott JA, Clark JA, Stark PC, Mitchell SP. J Urol; 2001 Aug 15; 166(2):494-9. PubMed ID: 11458054 [Abstract] [Full Text] [Related]
11. Cancer incidence after localized therapy for prostate cancer. Moon K, Stukenborg GJ, Keim J, Theodorescu D. Cancer; 2006 Sep 01; 107(5):991-8. PubMed ID: 16878323 [Abstract] [Full Text] [Related]
12. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. Nieder AM, Porter MP, Soloway MS. J Urol; 2008 Nov 01; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517 [Abstract] [Full Text] [Related]
13. Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy. Mabjeesh NJ, Chen J, Stenger A, Matzkin H. Urology; 2007 Sep 01; 70(3):548-53. PubMed ID: 17905113 [Abstract] [Full Text] [Related]
14. Predictive factors for erectile dysfunction in men with prostate cancer after brachytherapy: is dose to the penile bulb important? Macdonald AG, Keyes M, Kruk A, Duncan G, Moravan V, Morris WJ. Int J Radiat Oncol Biol Phys; 2005 Sep 01; 63(1):155-63. PubMed ID: 16111584 [Abstract] [Full Text] [Related]
16. Urinary and rectal complications of contemporary permanent transperineal brachytherapy for prostate carcinoma with or without external beam radiation therapy. Sarosdy MF. Cancer; 2004 Aug 15; 101(4):754-60. PubMed ID: 15305406 [Abstract] [Full Text] [Related]
18. Second primary cancer after radiotherapy for prostate cancer--a seer analysis of brachytherapy versus external beam radiotherapy. Abdel-Wahab M, Reis IM, Hamilton K. Int J Radiat Oncol Biol Phys; 2008 Sep 01; 72(1):58-68. PubMed ID: 18374503 [Abstract] [Full Text] [Related]
19. Prostate brachytherapy: a descriptive analysis from CaPSURE. Lee WR, Sharkey J, Cowan JE, DuChane J, Carroll PR, CaPSURE Investigators. Brachytherapy; 2007 Sep 01; 6(2):123-8. PubMed ID: 17434105 [Abstract] [Full Text] [Related]
20. Colorectal complications of external beam radiation versus brachytherapy for prostate cancer. Lesperance RN, Kjorstadt RJ, Halligan JB, Steele SR. Am J Surg; 2008 May 01; 195(5):616-20; discussion 620. PubMed ID: 18374892 [Abstract] [Full Text] [Related] Page: [Next] [New Search]